Skip to content

Clinical trials

Observational Amyloidosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Phase: Observational Country / region: Italy Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20171
20204
20212
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione IRCCS Policlinico San Matteo di Pavia3
Alnylam Pharmaceuticals2
Akcea Therapeutics1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Ionis Pharmaceuticals, Inc.1
Paolo Milani1
Pfizer1
University Hospital of Ferrara1
University of Messina1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis13
Amyloid Neuropathies, Familial4
Cardiomyopathies3
Amyloidosis, Familial2
Immunoglobulin Light-chain Amyloidosis2
Polyneuropathies2
Amyloid Neuropathies1
Aortic Valve Stenosis1
Atrial Fibrillation1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.